主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | 比尔及梅林达盖茨信托基金会 | 是 | 1955.76万 | 31.83% | 新增 | 新增 | -- |
| 2 | Entities affiliated with David E. Shaw | 是 | 1649.62万 | 26.85% | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2025-10-16 | Dugan Margaret |
|
2.46 | 21.07 | 是 | Chief Medical Officer |
| 2025-06-18 | Friesner Richard |
|
52.17 | 0.00 | 是 | -- |
| 2025-06-18 | OBEROI ARUN |
|
1.72 | 0.00 | 是 | -- |
| 2025-06-18 | GINSBERG GARY L |
|
1.72 | 0.00 | 是 | -- |
| 2025-06-18 | Thornberry Nancy |
|
1.72 | 0.00 | 是 | -- |
| 2025-06-18 | Kapeller-Libermann Rosana |
|
1.72 | 0.00 | 是 | -- |
| 2025-06-18 | van Kralingen Bridget A |
|
1.15 | 0.00 | 是 | -- |
| 2025-06-18 | Lynton Michael |
|
1.72 | 0.00 | 是 | -- |
| 2025-06-18 | Sender Gary |
|
1.72 | 0.00 | 是 | -- |
| 2025-06-18 | Chodakewitz Jeffrey |
|
1.72 | 0.00 | 是 | -- |
| 2025-05-29 | Aklian Mannix Vartan |
|
1.41 | 0.00 | 是 | EVP, Chief Commercial Officer, Global Head of Software Sales & Marketing |
| 2025-05-21 | Jain Rachit |
|
3.71 | 0.00 | 是 | EVP & CFO |
| 2025-04-14 | Akinsanya Karen |
|
2.90 | 3.22 | 是 | President of R&D, Therapeutics |
| 2025-04-14 | Akinsanya Karen |
|
3.23 | 2.92 | 是 | President of R&D, Therapeutics |
| 2025-04-14 | Akinsanya Karen |
|
2.40 | 25.11 | 是 | President of R&D, Therapeutics |
| 2025-04-14 | Akinsanya Karen |
|
1.90 | 25.11 | 是 | President of R&D, Therapeutics |
| 2025-04-14 | Akinsanya Karen |
|
1.56 | 25.00 | 是 | President of R&D, Therapeutics |
| 2025-03-07 | van Kralingen Bridget A |
|
1.00 | 0.00 | 是 | -- |
| 2025-03-06 | Herman Jenny |
|
2.73 | 21.11 | 是 | SVP & Controller |
| 2025-03-03 | Porges Geoffrey Craig |
|
1.82 | 0.00 | 是 | EVP & CFO |
| 2025-03-03 | Porges Geoffrey Craig |
|
3.30 | 0.00 | 是 | EVP & CFO |
| 2025-03-03 | Porges Geoffrey Craig |
|
2.75 | 21.76 | 是 | EVP & CFO |
| 2025-03-03 | Akinsanya Karen |
|
1.56 | 0.00 | 是 | President of R&D, Therapeutics |
| 2025-03-03 | Farid Ramy |
|
22.19 | 0.00 | 是 | President & CEO |
| 2025-03-03 | Dugan Margaret |
|
2.60 | 0.00 | 是 | Chief Medical Officer |
| 2025-03-03 | Lorton Kenneth Patrick |
|
5.36 | 0.00 | 是 | EVP, CTO & COO, Software |
| 2025-03-03 | Tran Yvonne |
|
2.36 | 0.00 | 是 | EVP, CLO & CPO |
| 2025-03-03 | Herman Jenny |
|
2.80 | 0.00 | 是 | SVP & Controller |
| 2025-03-03 | Abel Robert Lorne |
|
2.06 | 0.00 | 是 | EVP, Chief Scientific Officer, Platform |
| 2025-02-18 | Tran Yvonne |
|
1.50 | 4.34 | 是 | EVP, CLO & CPO |
| 2025-02-18 | Tran Yvonne |
|
1.11 | 28.00 | 是 | EVP, CLO & CPO |
| 2025-02-11 | Herman Jenny |
|
1.82 | 24.43 | 是 | SVP & Controller |
| 2025-02-11 | Tran Yvonne |
|
1.11 | 24.43 | 是 | EVP, CLO & CPO |
| 2025-02-11 | Lorton Kenneth Patrick |
|
4.11 | 24.43 | 是 | EVP, CTO & COO, Software |
| 2025-02-10 | Abel Robert Lorne |
|
0.81 | 25.99 | 是 | EVP, Chief Scientific Officer, Platform |
| 2024-10-15 | Dugan Margaret |
|
1.35 | 17.78 | 是 | Chief Medical Officer |
| 2024-06-18 | Chodakewitz Jeffrey |
|
1.13 | 0.00 | 是 | -- |
| 2024-06-18 | Lynton Michael |
|
1.13 | 0.00 | 是 | -- |
| 2024-06-18 | Kapeller-Libermann Rosana |
|
1.13 | 0.00 | 是 | -- |
| 2024-06-18 | OBEROI ARUN |
|
1.13 | 0.00 | 是 | -- |
| 2024-06-18 | Sender Gary |
|
1.13 | 0.00 | 是 | -- |
| 2024-06-18 | Thornberry Nancy |
|
1.13 | 0.00 | 是 | -- |
| 2024-06-18 | Friesner Richard |
|
51.57 | 0.00 | 是 | -- |
| 2024-06-18 | GINSBERG GARY L |
|
1.13 | 0.00 | 是 | -- |
| 2024-03-06 | Lorton Kenneth Patrick |
|
4.21 | 4.34 | 是 | EVP, CTO & COO, Software |
| 2024-03-04 | Porges Geoffrey Craig |
|
0.90 | 0.00 | 是 | EVP & CFO |
| 2024-03-04 | Porges Geoffrey Craig |
|
0.57 | 26.35 | 是 | EVP & CFO |
| 2024-03-04 | Herman Jenny |
|
1.91 | 0.00 | 是 | SVP & Controller |
| 2024-02-12 | Lorton Kenneth Patrick |
|
3.65 | 28.29 | 是 | EVP, CTO & COO, Software |
| 2024-02-12 | Herman Jenny |
|
1.18 | 28.29 | 是 | SVP & Controller |
| 2024-02-12 | Tran Yvonne |
|
1.20 | 28.29 | 是 | EVP, CLO & CPO |
| 2024-02-12 | Abel Robert Lorne |
|
0.93 | 27.55 | 是 | EVP, Chief Science Officer, Platform |